Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 158,545 | 276,774 | 153,298 | 104,139 | 585,578 |
| Marketable Securities | 79,879 | 207,841 | 125,283 | 184,512 | 70,831 |
| Receivables | 124,069 | 113,304 | 105,556 | 98,397 | 96,318 |
| Inventories | 152,863 | 125,282 | 104,353 | 96,063 | 98,550 |
| TOTAL | $547,974 | $745,130 | $509,994 | $498,334 | $866,048 |
| Non-Current Assets | |||||
| PPE Net | 140,690 | 167,169 | 173,927 | 183,512 | 188,401 |
| Investments And Advances | 22,308 | 35,649 | 38,459 | 37,209 | 0 |
| Intangibles | 388,314 | 425,970 | 646,501 | 703,789 | 769,143 |
| Other Non-Current Assets | 165,631 | 179,598 | 205,505 | 258,356 | 251,761 |
| TOTAL | $716,943 | $808,386 | $1,064,392 | $1,182,866 | $1,209,305 |
| Total Assets | $1,264,917 | $1,553,516 | $1,574,386 | $1,681,200 | $2,075,353 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 201,776 | 8,641 | 33,648 | 24,234 |
| Accounts payable and accrued liabilities | 15,150 | 19,133 | 15,698 | 15,220 | 10,543 |
| Accrued Expenses | 95,601 | 80,124 | 64,243 | 89,785 | 127,555 |
| TOTAL | $120,590 | $309,920 | $97,383 | $147,774 | $521,118 |
| Non-Current Liabilities | |||||
| Long Term Debt | 372,189 | 383,545 | 115,202 | 251,056 | 335,263 |
| Other Non-Current Liabilities | 74,814 | 81,703 | 491,671 | 507,360 | 488,564 |
| TOTAL | $451,216 | $465,248 | $606,873 | $758,416 | $823,827 |
| Total Liabilities | $571,806 | $775,168 | $704,256 | $906,190 | $1,344,945 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,490 | 46,276 | 46,501 | 45,952 | 44,848 |
| Common Shares | 48 | 47 | 46 | 46 | 45 |
| Retained earnings | -199,322 | -206,356 | -106,796 | -148,751 | -211,895 |
| Other shareholders' equity | 4,762 | 222 | 247 | -380 | 167 |
| TOTAL | $693,111 | $778,348 | $870,130 | $775,010 | $730,408 |
| Total Liabilities And Equity | $1,264,917 | $1,553,516 | $1,574,386 | $1,681,200 | $2,075,353 |